Geode Capital Management’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.68M | Buy |
794,008
+18,511
| +2% | +$62.4K | ﹤0.01% | 3040 |
|
|
2025
Q1 | $2.99M | Buy |
775,497
+13,857
| +2% | +$53.5K | ﹤0.01% | 2886 |
|
|
2024
Q4 | $4.7M | Buy |
761,640
+3,090
| +0.4% | +$19.1K | ﹤0.01% | 2777 |
|
|
2024
Q3 | $4.08M | Buy |
758,550
+50,579
| +7% | +$272K | ﹤0.01% | 2869 |
|
|
2024
Q2 | $2.37M | Buy |
707,971
+24,073
| +4% | +$80.7K | ﹤0.01% | 3077 |
|
|
2024
Q1 | $2.76M | Buy |
683,898
+21,154
| +3% | +$85.3K | ﹤0.01% | 2987 |
|
|
2023
Q4 | $1.76M | Buy |
662,744
+28,024
| +4% | +$74.3K | ﹤0.01% | 3154 |
|
|
2023
Q3 | $1.5M | Sell |
634,720
-2,125
| -0.3% | -$5.02K | ﹤0.01% | 3175 |
|
|
2023
Q2 | $4.01M | Buy |
636,845
+3,837
| +0.6% | +$24.2K | ﹤0.01% | 2811 |
|
|
2023
Q1 | $3.65M | Buy |
633,008
+29,995
| +5% | +$173K | ﹤0.01% | 2771 |
|
|
2022
Q4 | $6.19M | Buy |
603,013
+26,304
| +5% | +$270K | ﹤0.01% | 2546 |
|
|
2022
Q3 | $9.64M | Buy |
576,709
+141,584
| +33% | +$2.37M | ﹤0.01% | 2290 |
|
|
2022
Q2 | $6.09M | Buy |
435,125
+68,380
| +19% | +$957K | ﹤0.01% | 2590 |
|
|
2022
Q1 | $5.92M | Buy |
366,745
+15,304
| +4% | +$247K | ﹤0.01% | 2703 |
|
|
2021
Q4 | $7.52M | Buy |
351,441
+93,409
| +36% | +$2M | ﹤0.01% | 2641 |
|
|
2021
Q3 | $3.79M | Buy |
258,032
+5,272
| +2% | +$77.4K | ﹤0.01% | 3069 |
|
|
2021
Q2 | $5.03M | Buy |
252,760
+215,060
| +570% | +$4.28M | ﹤0.01% | 2906 |
|
|
2021
Q1 | $1.13M | Buy |
+37,700
| New | +$1.13M | ﹤0.01% | 3503 |
|